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Abstract
The health effects of cannabis use may not always be seen as a high priority for Aboriginal and Torres
Strait Islander communities. However, the impact of cannabis use on physical and mental health can have
significant consequences. It is known that the use of high potency cannabis has increased over the last
two decades, with a corresponding increased risk to health. In particular, young people are at increased
risk of experiencing harms to mental health. Physical harms to health include effects on the respiratory
system, cardiovascular system, an increased risk of cancer, and in-utero effects from maternal use. The
review notes concern that in countries where there has been commercialisation of cannabis use, there
has been an increase in the rate and use of high potency products. While generalising findings about
cannabis use for Aboriginal and Torres Strait Islander people is problematic due to limited data, high rates
of cannabis use have been found in some remote communities. The review highlights the protective
factors that reduce harms from cannabis use and suggests future directions for a collaborative approach
to addressing cannabis related harms in communities.
This review is part of a suite of knowledge exchange products that includes a summary, a video, and a
fact sheet.
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About this review
The purpose of this review is to provide a comprehensive synthesis of key
information on cannabis use among Aboriginal and Torres Strait Islander people in
Australia to:
•

inform those involved or who have an interest in Aboriginal and Torres
Strait Islander health and, in particular, cannabis use.

•

provide evidence to assist in the development of policies, strategies and
programs.

The review provides general information on the social and cultural context of
cannabis use, and the factors that contribute to cannabis related harms. It provides
information on the extent of cannabis use and discusses the protective and risk
factors in relation to cannabis use. The review provides information on relevant
programs, services, policies and strategies that address cannabis use among
Aboriginal and Torres Strait Islander people. It concludes by discussing possible
future directions for culturally secure approaches to addressing harms from
cannabis use for Aboriginal and Torres Strait Islander people in Australia.
This review draws mostly on journal publications, government reports, national
data collections and national surveys, the majority of which can be accessed
through the Australian Indigenous HealthInfoNet’s publications database:
https://healthinfonet.ecu.edu.au/key-resources/publications.
Information specifically about cannabis use can be found at:
https://aodknowledgecentre.ecu.edu.au/learn/specific-drugs/cannabis/. This was
not a systematic literature review in that not all articles were synthesised or
assessed in the review. Rather, it was a scoping review, whereby the articles
collected were used as the basis of the review, with further information sought
during the drafting process.
The HealthInfoNet, consistent with its nomenclature guide, prefers the term
‘Aboriginal and Torres Strait Islander’ rather than ‘Indigenous Australian’ for its
publications. Also, some sources may use the terms ‘Aboriginal’ only or ‘Torres
Strait Islander’ only. However, when referencing information from other sources,
authors may use the terms from the original source. As a result, readers may see
these terms used interchangeably in some instances. If they have any concerns,
they are advised to contact the HealthInfoNet for further information.
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Introduction
1

Cannabis is the most widely used drug worldwide (UNODC, 2020, 2021). The United
Nations Office of Drugs and Crime (UNODC) estimates that there are approximately 200
million cannabis users across the globe (UNODC, 2021). Cannabis is illegal to cultivate,
distribute and consume across much of the globe, despite recent changes in the
Americas. In Australia, cannabis is listed as a narcotic drug under the Narcotics Drug Act,
1967 (Australian Drug Foundation, 2021); although laws vary between the states it is
illegal to cultivate, possess, supply, use, or drive under the influence of cannabis. In both
South Australia and the Australian Capital Territory possession of small amounts of
cannabis for personal use is legal (Australian Drug Foundation, 2021).
The term cannabis refers to the plant Cannabis sativa L, and its products including
dried leaf and bud matter, and resin. Although debated in the literature, Cannabis sativa
L. is currently classed as monospecific; it has two subspecies – Sativa and Indica – and a
further four varieties (Bloomfield et al., 2019; UNODC, 2021). Cannabis is grown in many
regions around the world, including Australia, and the majority of cannabis trafficking in
Australia is intrastate, although the international illicit trade does provide cannabis to the
Australian market (UNODC, 2021). Cannabinoids are the psychoactive substances in
cannabis. To date, 120 phytocannabinoids have been identified for C.sativa. The main
psychoactive cannabinoid is delta9-tetrahydrocannabinol (THC) (UNODC, 2021).
Cannabis is typically consumed to experience the effects of THC. Another cannabinoid of
note is cannabidiol (CBD). CBD does not have the same psychoactive effects as THC
and may moderate some of its effects (Bloomfield et al., 2019). In the following paper, the
term cannabis use relates to the use of THC containing plant material (leaves, buds, oil
and resin) for recreational purposes. The following paper does not discuss the use of
cannabis extracts, medicinal cannabis or synthetic cannabis.
There are three main cannabis products, these are the dried leaf and bud material
(herb or marijuana), cannabis resin (hashish) and cannabis oil (derived from the resin –
hashish oil) (Australian Criminal Intelligence Commission, 2020). In Australia cannabis is
known by a wide variety of slang terms including: gunja, ganja, weed, grass, pot, dope,
mull, yarndi, hydro, Mary Jane, and choof among others (Australian Drug Foundation,
2021). Cannabis is consumed via two routes of administration – smoking and eating.
Smoking leaf and bud material is the most common route of administration, typically
using either a dry pipe, cigarette (joint, blunt) or a water pipe (bong). Hashish and hashish
oil are often added to leaf material when smoked (Australian Criminal Intelligence
Commission, 2020). Of note, tobacco is also often added to smoked cannabis (Hindocha
et al.,2016). Using cannabis via e-cigarettes or vaporisers is increasing in popularity.
Vaping cannabis can include both vaporising cannabis extracts or dried herb matter
(Budney et al., 2015). There is a lack of research regarding recreational smoking of
cannabis via e-cigarettes and its consequences (Budney et al., 2015; Chaiton et al.,
2022). Thus, the majority of the review below does not specifically focus on vaping.
Cannabis can also be ingested through foods (e.g. brownies, cookies) or beverages (e.g.
tea, brew) containing cannabis (Swan et al., 2021).
THC is absorbed into the blood stream either via the lungs for smoked products or
via the stomach for eaten cannabis, it then activates receptors in the brain to produce a
‘high’, commonly known as being ‘stoned’. More specifically, THC produces a range of
dose dependent effects on both neurocognitive and pharmacological systems and is a
central nervous system depressant (Curran et al., 2016). THC acts directly with the
endocannabinoid system (it is a partial agonist at cannabinoid type 1 receptors) and
indirectly on the glutamatergic, GABAergic and dopaminergic systems (Bloomfield et al.,
2019) with resultant effects on executive functioning, emotion, reward and memory
processing. THC effects brain regions such as the hippocampus, amygdala, cerebellum,
thalamus and basal ganglia (Bloomfield et al., 2019).
1

Refers to substances controlled under the international drug control conventions, and their non-medical
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The pleasurable effects associated with THC include euphoria, relaxation, sensory
intensification (Bloomfield et al., 2019; Curran et al., 2016), increased sociability and
spontaneous laughter and excitement (Australian Drug Foundation, 2021). Intoxication
can result in the adverse effects of cognitive impairment (including memory), anxiety,
paranoia, dry mouth, and occasionally psychotic-like symptoms (Curran et al., 2016;
Green et al., 2003).
THC produces dose dependent effects, yet the THC content of cannabis products its potency - varies greatly. THC concentration is lower in leaves than buds, and highest
in resin (Lorenzetti et al., 2021). As noted by UNODC (UNODC, 2021) there has been a
rapid advancement in the cultivation of cannabis over the last two decades which has
resulted in an increase in potency of cannabis (Freeman et al., 2021; UNODC, 2021).
The average concentration of flower products can exceed 20% and of concern, very high
potency flower (60 – 80% THC) has been identified (Chan & Hall, 2020; Freeman et al.,
2021). Considering this and the different ways people use cannabis in order to either
maximise or moderate their THC consumption (Curran et al., 2016), the standardised
assessment of cannabis use without biological measures is challenging.
The following paper will review the known effects of cannabis on health, mental
health and psychosocial variables. It will then review the context of cannabis use in
Australia more broadly before focusing specifically on the extent of use and related harms
among Aboriginal and Torres Strait Islander Australians. The review will then present a
summary of best practice in responding to cannabis related harms for Aboriginal and
Torres Strait Islander Australians (herein the term Aboriginal will be respectfully used)
and include a brief discussion of policy relating to cannabis use, before identifying areas
for future research.
In reviewing the literature for the present paper, it is important to note the challenges
in conducting research regarding the recreational use of cannabis. Firstly, as noted
above, cannabis use is particularly challenging to quantify. This is due to a range of
reasons including varying rates of THC concentration, varying modes of administration
(Lorenzetti et al., 2021) and the impact of tobacco mixed with cannabis (Rooke et al.,
2013). These factors all impact the validity and comparability of self-report data, from
which the vast majority of cannabis research is based. Secondly, the focus of much
research into cannabis has been limited, with the majority of literature assessing either
lifetime, or, past year use of cannabis, thereby not assessing frequency, quantity, or
pattern of use (e.g. high episodic use, low frequent use). Research which asks only about
frequency of use is unable to account for quantity of use, which may be widely variable
(Lorenzetti et al., 2021), and as such there is a dearth of research regarding heavy
cannabis use, or that distinguishing heavy use from other patterns of use. This lack of
specificity prevents more nuanced examination of the effects of differing cannabis use
patterns. Furthermore, there has been disproportionate research on young adult and
adolescent users who may yet have experienced long term effects (Rooke et al., 2013)
thus limiting the capacity to fully understand long term risks of cannabis use. Thirdly, due
to the illegal status of cannabis it is possible that willingness to disclose use may be
impacted. Finally, with regards to research among Aboriginal communities the majority of
detailed research has been conducted within remote communities, or with vulnerable
populations such as people involved with the justice system consequently generalising
the findings is problematic and many of the findings discussed cannot be considered
representative of all Aboriginal people.

Known impacts of cannabis use
The toxicity of cannabis use is considered very low (Zahra et al., 2020) with a recent
review of cannabis related deaths in Australia recording no known cases of cannabis
toxicity leading to death. Despite this, and the challenges associated with research noted
above, there are a number of acute and chronic cannabis related harms that are well
established in the literature and have implications for mortality, wellbeing and for public
health more broadly (Hall et al., 2019; Zahra et al., 2020).

Published by Edith Cowan University, 2022
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Health
A number of reviews have identified a range of negative health effects associated with
cannabis use (Campeny et al., 2020; Hall, 2009, 2014; Hall & Degenhardt, 2006; Hall et
al., 2019; Zahra et al., 2020). These include effects on the respiratory system,
cardiovascular system, cognitive function, psychomotor impairment, risk of cancer, inutero effects from maternal use and sleep.
Cannabis which is smoked has an adverse effect on the respiratory system; smoked
cannabis can contain more tar and polycyclic aromatic hydrocarbons than smoked tobacco
(Rooke et al., 2013). Acute cannabis smoking can cause coughing and throat irritation (Hall,
2015). Chronic cannabis smoking is linked to chronic bronchitis and there is growing evidence
for cannabis-related impairment of respiratory function including wheezing, exercise-related
shortness of breath, nocturnal wakening with chest tightness, morning sputum, coughing,
chest sounds and phlegm production (Agrawal et al., 2012; Campeny et al., 2020; Gracie &
Hancox, 2021). Of note, the effects on the respiratory system occur independently of tobacco
use but tobacco and cannabis use can have an additive effect (Rooke et al., 2013), including
central airway resistance, lung hyperinflation and higher vital capacity (Gracie & Hancox,
2021). There is no convincing evidence that cannabis smoking leads to chronic obstructive
pulmonary disorder (COPD) independently of tobacco use (Gracie & Hancox, 2021).
Although not consistently demonstrated, there is a potential relationship between cannabis
use and lung cancer (Campeny et al., 2020; Gracie & Hancox, 2021; Rooke et al., 2013).
Cannabis use can result in cardiovascular complications, including acute coronary
syndrome, vasospasm and arrhythmias (Jouanjus et al., 2014), particularly among naïve
users (Hall, 2015), and an increased risk of angina for those with heart disease (Hall,
2014). A review of global case reports and epidemiological studies has highlighted the
need to acknowledge cannabis as a contributing cause of sudden unexpected death,
especially of cardiac and cerebrovascular nature (Zahra et al., 2020).
A recent systematic review of systematic reviews by Campeny and colleagues
(Campeny et al., 2020) concluded that there is sufficient evidence to support the
assertion that cannabis has a negative impact on cognition that persists after intoxication
and is present when controlling for baseline function. Memory, executive functioning and
learning are all impacted by cannabis use (Campeny et al., 2020). Longitudinal research
has identified that sustained cannabis use over several decades can produce substantial
differences in cognitive performance that may not be wholly reversible which is strongest
for those whose onset of use is in adolescence (Hall, 2009). Hall surmised that cannabis
users have lower attention and memory than non-cannabis users (Hall, 2014).
Cannabis use can result in acute psychomotor impairment (Hall, 2009, 2014), in
conjunction with cognitive impairment this can lead to an increase in risk for accidental
injury and motor vehicle accidents (Leikin & Paloucek, 2007), indeed acute cannabis
intoxication is associated with a two-fold increase in the risk of road traffic accidents
(Asbridge et al., 2016; Els et al., 2019; Li et al., 2012).
Emerging evidence also suggests that cannabis use during pregnancy has an impact
on maternal and child health. Research in this area is highly challenging due to multiple
confounds including tobacco use, under-reporting of cannabis use and complex social
determinants. That said, there is strong evidence that maternal cannabis use is linked to
low birth weight (Campeny et al., 2020; Eiden et al., 2020; Hall, 2009, 2014; Sturrock et
al., 2020). Some studies have demonstrated a correlation between maternal cannabis
use and later behavioural problems and developmental delays in children (Day et al.,
1994; Fried & Smith, 2001), however, Hall described the quality of studies and potential
confounds related to maternal cannabis use and post-natal child behaviour and
presentation as challenging (Hall, 2014). Finally there is some evidence that maternal
cannabis use may be related to birth complications and increased risk of admission to
infant neonatal intensive care units (Campeny et al., 2020).
The relationship between cannabis use and an increased risk of cancer is not clear
cut. In summarising the literature Hall (Hall, 2014) concluded that although research has
found that THC and other cannabinoids have not been identified as potential
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carcinogens, cannabis smoke is carcinogenic. As a result, the focus of research has been
on the potential involvement of cannabis smoking on cancers of the lung, mouth, tongue,
oesophagus and bladder (Hall, 2014), a field challenged by the co-use of cannabis and
tobacco. To date, there is no evidence that cannabis use increases the risk of head and
neck cancers (Campeny et al., 2020). As mentioned above there is mixed evidence of a
relationship between cannabis and lung cancer; Campeny (Campeny et al., 2020)
concluded that cannabis smoking increases the risk of lung cancer somewhere between
8% and 410% after adjusting for confounding factors. The incredible risk range resulted
from the heterogeneity of samples and study designs (Campeny et al., 2020). Systematic
reviews have concluded that there is evidence to support a correlation between cannabis
use and testicular cancer (non-seminoma-type testicular germ cell tumours) in males
(Campeny et al., 2020) (Hall, 2014).
Finally, cannabis use can affect sleep functioning. Acute, recreational use of cannabis
can result in non-restful sleep and may interrupt slow wave sleep (Gates et al., 2016).

Social and emotional wellbeing
Research has consistently demonstrated a relationship between cannabis use and
mental ill-health (Campeny et al., 2020) (Hall, 2014), including, cannabis dependence,
psychosis, depression, anger, acute anxiety and elevated risk of suicide. It is important to
note that cannabis may be related to mental ill-health due to a variety of mechanisms,
including increased vulnerability for cannabis-related psychiatric disorders, poorer
prognosis for pre-existing psychiatric disorders, self-medication hypotheses and the
possibility of cannabis-medication interactions (Hudson & Hudson, 2021).

Cannabis dependence
Cannabis dependence, referred to as Cannabis Use Disorder (CUD) within the Diagnostic
and Statistical Manual of Mental Disorders (DSM-V), is defined as a problematic pattern of
cannabis use leading to clinically significant impairment or distress (Hasin et al., 2013).
Diagnosis requires two of the following occurring within a 12-month period: tolerance,
withdrawal, inability to control consumption, craving, recurrent use causing negative
impacts in role obligations including home, school and work, continued use despite
negative consequences, hazardous use of cannabis, continued use despite knowledge of
harms, and that cannabis (or a closely related substance) is taken to relieve or avoid
withdrawal symptoms (American Psychiatric Association, 2013; Teesson et al., 2002).
An estimated 10% of people who use cannabis become dependent (Hamilton, 2019),
thus most users will not become dependent. While this percentage is markedly lower than
other drugs such as nicotine and heroin, reviews have also noted that the risk of
developing CUD is greater for those who commence use in adolescence, use cannabis
daily or weekly, or use cannabis with tobacco (Campeny et al., 2020; Hall, 2014; Peters,
Budney, & Carroll, 2012; Teesson et al., 2002). Indeed within a community sample in
Australia, 54% of cannabis users who used at least five times in the past year met criteria
for cannabis dependence (Teesson et al., 2002). More recently Lorenzetti and colleagues
noted that increases in THC content are related to increasing rates of cannabis
dependence (Lorenzetti et al., 2021).
In considering cannabis dependence it is important to note the impact of cannabis
withdrawal for those who quit or attempt to quit cannabis, and its potential discomfort,
harm and impact on motivation to quit (Budney et al., 2008). Cannabis withdrawal
symptoms include: depressed mood, anger, aggression, headaches, sweating/heart
racing, restlessness, shakiness, nausea, stomach pain, decreased appetite, decreased
body weight and sleep problems (American Psychiatric Association, 2013). There is
increasing recognition in the literature of increases in anger, aggression and violence as
a component of cannabis withdrawal (Budney et al., 2003; Lee et al., 2015; Smith, 2013).
The onset of withdrawal typically occurs between days 1–3, with peak effects between
days 2–6, and most effects last 4–14 days (Budney et al., 2003). Of note those who use
both cannabis and tobacco are more likely to report cannabis withdrawal syndrome
symptoms (Peters et al., 2012).
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Psychosis
Despite a complex relationship, review of the literature suggests that cannabis use is a
risk for psychosis (delusions, hallucinations and disordered thinking) and the diagnosis of
schizophrenia (Bloomfield et al., 2019; Campeny et al., 2020; Curran et al., 2016; Gage
et al., 2016; Mattick & McLaren, 2006). Whilst a pre-existing vulnerability to psychosis is
an important factor in the relationship between the two (McLaren et al., 2010), cannabis
use has an impact on incidence and prevalence of psychotic experiences (Linscott & van
Os, 2013). Importantly age at onset of psychosis among clinical samples is 2.7 years
earlier for cannabis users compared to non-users (Large et al., 2011).
Pattern of cannabis use is an important consideration with use at a younger age and
heavier use more likely to predict onset of psychosis (Campeny et al., 2020). More recently
there has been a focus on the potency of cannabis and the relationship with psychosis. In
summarising the literature Lorenzetti and colleagues (Lorenzetti et al., 2021) noted that
long term use of high THC cannabis was related to an increased risk of psychotic disorders.
Further high potency cannabis impacts the course of psychoses, with use following a first
episode of psychosis related to an increased risk of relapse, shorter time to relapse, and
high intensity of psychiatric care. At a population level higher potency cannabis is related to
increases in first-episodes of psychosis (Lorenzetti et al., 2021).

Mood disorders
Cannabis use may represent a risk factor for depression, particularly among those who
use cannabis heavily (Campeny et al., 2020) and it has been suggested that this
relationship may be stronger among those who also use tobacco (Peters et al., 2012).
Similarly, cannabis use is also a risk factor for the development of bipolar disorder
(Campeny et al., 2020), with greater risk related to higher levels of use. While population
level and cohort studies have found mixed results and are largely challenged by
confounding factors, research in clinical samples consistently demonstrates higher levels
of cannabis use than among non-clinical samples. Research has also suggested that
cannabis use may worsen symptoms in those experiencing depression or bipolar disorder
(Hall, 2014)( Smolkina et al., 2017) (Cuttler et al., 2018; Lagerberg et al., 2016).

Anxiety and anxiety disorders
The acute effects of cannabis intoxication can include anxiety and paranoia. There is
some suggestion that this may result in presentations to emergency departments and
ambulance call outs (Kaar et al., 2015; Zahra et al., 2020). Hall (Hall et al., 2019)
proposed that the increase in potency of THC may have increased the risk of high acute
anxiety particularly for naive users. Cannabis use is considered a risk factor at the
population level for the development of anxiety disorders (Campeny et al., 2020).

Suicide risk
Cannabis use has been linked to suicide in a number of studies, and cannabis is
considered a risk factor for death by suicide (Campeny et al., 2020) and suicidal ideation
(Carvalho et al., 2019). However, a clear causal pathway has not been established and
the majority of research has not controlled for potential confounding variables related to
suicide (e.g. depression and alcohol use) (Calabria et al., 2010). Weekly cannabis use
has also been found to be independently associated with a five-fold increase in self-harm
among females (Patton et al., 2005).

Psycho-social harms associated with cannabis use
Cannabis use has been linked to a number of social harms in the literature; indeed cannabis
users appear to report lower overall health and life satisfaction compared to non-using peers
(Agrawal et al., 2012). Numerous studies have demonstrated a relationship between regular
cannabis use in adolescence and risks of leaving school early (Stiby et al., 2015). In addition it
is related to the use of other illicit drugs, tobacco use, heavy alcohol use and not being in a
relationship when followed up at age 30 years (Chan et al., 2021). These associations persist
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after controlling for plausible confounding variables in longitudinal studies; however, as noted
by Hall, there are potential shared causes or risk factors (Hall et al., 2019).
The relationship between cannabis use and other drug use is worthy of comment
with cannabis use often being considered as a ‘gateway’ drug to further drug use (Hall &
Lynskey, 2009), thus being a risk factor for other illicit drug use. Cannabis use is
demonstrably higher among those who use other illicit drugs than those who do not in
general population studies, and regular and early cannabis use predicts other drug use
(Hall & Lynskey, 2009). Furthermore, considering that cannabis use is more strongly
associated with other illicit drug use than either alcohol or tobacco use, Hall and Lynskey
(Hall & Lynskey, 2009) argue that although the gateway pattern may be explained by the
common characteristics of those who use cannabis and other drugs, young people who
are the earliest and most frequent cannabis users, are the most likely to use other illicit
drugs. Similarly, given the common practice of mixing tobacco in with cannabis, cannabis
use provides an avenue for nicotine addiction (Hindocha et al., 2017; Rooke et al., 2013).

Summary of cannabis related harms
Cannabis then is associated with a range of harms, yet the research is complex and clear
causal pathways have been difficult to identify. In drawing conclusions from a systematic
review of systematic reviews Campeny and colleagues (Campeny et al., 2020) affirmed that
cannabis use is a risk factor for motor vehicle collisions, suicidal ideation, anxiety, depression,
lower educational attainment and respiratory outcomes. In addition they identified that
cannabis use was associated with testicular cancer, impaired cognitive function, lung cancer
and other drug use (Campeny et al., 2020). Results of this and other reviews emphasise the
potential harms of cannabis on mental health, with the evidence that adolescent cannabis use
has a relationship with psychosis and incidence of schizophrenia, increased risk of depression
and bipolar, and can result in persistent anxiety symptoms (Campeny et al., 2020).

The potential for low risk use
Despite these concerns and the public health implications of cannabis related harms it is
important to keep these harms in perspective. For example, in the Global Burden of
Disease project, regular cannabis use was found to produce much less harm than regular
alcohol and tobacco use (Degenhardt et al., 2013). In Australia cannabis makes a smaller
contribution to disease burden than opioids despite the much lower prevalence of opiate
use (Hall et al., 2019). There is a lack of knowledge about what level of use is nonproblematic (Curran et al., 2016). A recent review proposed to develop lower risk use
guidelines (Fischer et al., 2021), suggesting that delaying the use of cannabis until after
adolescence, avoiding high potency cannabis, avoiding smoking based administration,
and avoiding high frequency and high intensity use would minimise much of the potential
harms associated with cannabis use. Further in determining the potential for low risk use
they emphasised the need for particular caution among pregnant women, drivers, older
adults and those with health comorbidities (Fischer et al., 2021).

The context for cannabis use among Aboriginal and Torres Strait
Islander people in Australia
Australian context of cannabis use
Much like the rest of the globe, cannabis is the most used illicit drug in Australia. In 2021,
the past year prevalence (having tried cannabis at least once in the last year) in Australia
was approximately 12% of the adult population (UNODC, 2021). The National Drug
Strategy Household Survey (NDSHS) conducted in 2019 estimated a lifetime prevalence
(having ever used in one’s life) of cannabis use in Australia for those aged 14 years and
over of 36% and a past year prevalence of 12% (Australian Institute of Health and
Welfare, 2020b). This was an increase from 2016 (35% and 10% respectively) which is
noteworthy as cannabis use rates had remained stable for the previous decade (UNODC,
2021). Among respondents in the 2019 NDSHS who had used cannabis, 37% reported
using cannabis at least weekly.
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Further results from the NDSHS indicate that prevalence rates are highest among
young adults than other age groups (past-year prevalence aged 20–29 years - 24%) and
that use among older adults is increasing (past-year use of cannabis increased from
7.2% in 2016 to 9.2% in 2019 for 50-59 year olds, and, from 1.9% to 2.9% for 60 years
and older) (UNODC, 2021); the latter suggesting an ageing cohort of cannabis users in
Australia (Australian Institute of Health and Welfare, 2020b; UNODC, 2021). The NDSHS
data identified males over the age of 14 years as using more recently and more
frequently than females. They were more likely to have used cannabis in the past week
(15% compared to 8.6%) (Australian Institute of Health and Welfare, 2021b) and to do so
at a higher frequency (41% of cannabis using males use once a week or more, compared
to 31% of female cannabis users) (Australian Institute of Health and Welfare, 2021b, Hall,
2009).
The data suggest that the majority of people who use cannabis in Australia do not do
so at levels commensurate with high risk. The NDSHS included questions in 2019 aimed
at identifying high risk use, they identified that 82% of cannabis users were low risk
(Australian Institute of Health and Welfare, 2020b). Consistent with this, examination of
data between 2007 and 2016 found that only one in six cannabis users were daily users,
and daily users accounted for more than 80% of the estimated cannabis consumed in
Australia (Chan & Hall, 2020). The NDSHS data demonstrate a relationship between
cannabis and mental health at the population level, where those who reported mental
health conditions were more likely to consume cannabis than those who did not
(Australian Institute of Health and Welfare, 2020b, 2021b). Other characteristics of
cannabis use in Australia drawn from a range of government sources and summarised by
the AIHW include higher rates of use in rural areas compared to urban areas (as
measured via wastewater), high rates of cannabis use among prison entrants, and high
rates of cannabis use among those who use other illicit drugs (Australian Institute of
Health and Welfare, 2021b).
Considering the heightened harms associated with using cannabis from
adolescence, data from the Australian Secondary School Alcohol and Drug Survey
(ASSAD) provide important information. In the most recent ASSAD conducted in 2017,
17% of secondary students who participated had used cannabis in the past year, and 8%
had used in the past month. This was an increase since a previous survey in 2011 (15%
and 7% respectively) (Guerin, 2018). Importantly, cigarette smoking has been identified
as a significant predictor of both initiation and persistence of cannabis use during the later
school years (Coffey et al., 2000).
There is limited evidence as to the degree to which cannabis related harms are
present in the Australian community, however examination of the social costs of cannabis
estimated that cannabis costs Australia 4.5 billion dollars per annum, with the primary
costs related to law enforcement and crime. Also included in this are estimates of
approximately 152,000 people dependent on cannabis and 3,422 cannabis attributable
adult prison sentences (Whetton et al., 2020). Interestingly, evidence of a potential
increase in cannabis use and related harms comes from data trends suggesting
ambulance call outs related to cannabis use are increasing (Kaar et al., 2015). The
National Minimum Dataset for Alcohol and other Drug Treatment Services (AODTS NMD)
collects data from drug treatment services as part of the National Drug Strategy (NDS)
(Australian Institute of Health and Welfare, 2021a) and highlights that cannabis use
places a burden on the AOD treatment sector. Data suggests that cannabis use is the
primary drug of concern in 18% of closed treatment episodes (including education,
counselling, case management, residential rehabilitation, and detoxification) for people
entering AOD treatment (Australian Institute of Health and Welfare, 2021a). Furthermore,
over the past decade, treatment episodes for cannabis use have increased by 27%
(rising from 31,700 to 40,300 episodes). Among young people (aged 10 – 19 years)
cannabis was the primary drug of concern for 59% of treatment seekers (Australian
Institute of Health and Welfare, 2021a), highlighting the high level of treatment need for
cannabis among young people.
A final point regarding cannabis use in Australia was the finding in the 2019 NDSHS
that attitudes regarding cannabis use became more favourable since 2016 (Australian
Institute of Health and Welfare, 2020b). This is consistent with concerns raised by the
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UNODC who highlighted that cannabis is currently increasing in potency yet social
acceptability and perceptions of harm associated with cannabis use are decreasing
(UNODC, 2021).

Historical, social and cultural factors related to cannabis use among
Aboriginal and Torres Strait Islander people
Before turning to address the use of cannabis by Aboriginal people it is important to
acknowledge the socio-cultural context within which cannabis use occurs. As a result of
both historic and enduring colonisation, dispossession of land, language and culture,
child removal and entrenched systemic racism, Aboriginal people have greater exposure
to social disadvantage including life stressors, traumatic events and lack of adequate
service provision which are all factors associated with alcohol and other drug (AOD) use
and challenges to social and emotional health (Dudgeon et al., 2014a). This social
disadvantage occurs against a backdrop of overt and covert racism against Aboriginal
people which still exists, and operates at a cultural, institutional, and individual level
(Dudgeon et al., 2014a; Paradies, 2005; Priest et al., 2013). AOD use, including cannabis
use, can then also become a risk factor for further marginalisation and ill-health. Indeed,
cannabis use can occur within a context of chronic health and mental health conditions.
These factors are important to consider not only in understanding prevalence and
patterns of cannabis use among Aboriginal people, but also in reviewing research
undertaken, and developing appropriate prevention and intervention approaches.
Furthermore, these challenges which face Aboriginal communities impact on the
available human and financial resources that can be allocated to reducing cannabis use.

Extent of cannabis use among Aboriginal and Torres Strait Islander
people in Australia
Cannabis use rates (including by sex, age) current and recent trends
Despite the fact that cannabis is the most commonly used illicit drug globally, in Australia
there is scant epidemiological data regarding cannabis use and related harms among
Aboriginal people. The majority of research to date is limited to prevalence data collected
from large national surveys. The data presented below are drawn from the 2018-2019
National Aboriginal and Torres Strait Islander Health Survey (NATSIHS), the Aboriginal
cohort within the NDSHS and the ASSAD. It important to acknowledge that these national
level surveys tend to underestimate actual consumption (Gray & Wilkes, 2010a;
Stockwell et al., 2004); furthermore, adequate sampling from remote areas is not always
possible, therefore findings must be interpreted with caution.
Data from the 2018-2019 NATSIHS identified that 25% of participants (over 15
years) used cannabis within the previous month. Use was higher among males (31%)
than females (18%) (Australian Bureau of Statistics, 2019). There was an increase in past
year prevalence from 2008 to 2018−19, from 14% to 25% in remote areas and from 18%
to 24% in non-remote areas (although reliability of remote area data is limited) (Australian
Bureau of Statistics, 2019; Australian Institute of Health and Welfare, 2021b).
The data consistently show higher prevalence and higher levels of consumption of
cannabis among Aboriginal people compared to non-Aboriginal people (Australian
Bureau of Statistics, 2004, 2008, 2010, 2019). Data published by the Australian Bureau of
Statistics and the Australian Institute of Health and Welfare estimate previous 12-month
prevalence of cannabis use among Aboriginal respondents as 16% (a smaller prevalence
than that identified in the NATSIHS). Whereas the estimate for the general Australian
population is 12%, suggesting Aboriginal people are 1.3 times more likely to have used
cannabis (Australian Bureau of Statistics, 2019). These comparisons must be considered
in the socio-historical context in which Aboriginal people use cannabis, and are presented
to illustrate the potential for cannabis use to contribute to the health gap experienced by
Aboriginal people and not to contribute to a deficit based discourse (Colonna et al., 2020;
Fogerty et al., 2018).

Published by Edith Cowan University, 2022

9

Journal of the Australian Indigenous HealthInfoNet, Vol. 3 [2022], Iss. 3, Art. 1

Young people are a population of considerable interest and results from a number of
studies suggest high rates of use. The ASSAD found that the majority of secondary
students who identified as Aboriginal had used cannabis in the past month (58%), and
had a higher likelihood (adjusted odds ratio 1.97) of ever having used cannabis than nonIndigenous students (Heris et al., 2020). Similarly, a study of secondary school children in
NSW reported that Aboriginal students were more likely to use cannabis than nonAboriginal students, and were more likely to initiate use earlier and use more frequently
(Forero et al., 1999). In contrast to these findings, data among 15 - 29-year-old
participants in the NATSISS reveal that the majority of young people have never tried
cannabis (71%) (Australian Bureau of Statistics, 2019; Graham 2018).
Data from The Goanna Study - a cross-sectional survey of just under 3000 Aboriginal
young people aged 16–29 years which focused on sexual health and relationship - asked
a number of questions about drug use (Ward et al., 2014). They found that just over 35%
had used an illicit substance in the last year; cannabis was the most frequently used drug
with 30% of respondents having used it in the last year. Among those who used cannabis
37% used daily and 24% weekly or more, suggesting the majority of those who did use
cannabis did so regularly (Ward et al., 2014). Taken together the data suggest that
cannabis use is prevalent among young Aboriginal people and that rates of frequent use
are concerning.
The exception to the broad prevalence data described above is the work by Clough
and colleagues (Clough, 2005; Clough, D'Abbs et al., 2004; Clough, Cairney et al., 2004;
Clough et al., 2005; Clough et al., 2002; Clough et al., 2006; Lee et al.,2007; Lee et al.,
2008; Lee et al., 2009; Lee et al., 2009) whose work in Arnhem Land documented a rapid
rise in cannabis use in the late 1990s and early 2000s. The research, although now
somewhat dated, described the characteristics and impacts of cannabis use in a number
of small communities; their research revealed very high prevalence of cannabis use. In
one study they reported a lifetime prevalence of cannabis use of 77% for males and 61%
for females in a sample of 190 people (aged 17-36 years) from three remote communities
in Arnhem Land (Clough, 2005). Among those who did use cannabis. 24% did so weekly
or more frequently. In a separate study (Clough, D'Abbs, et al., 2004) estimated past
week rates of cannabis use were as high as 73% in males and 27% in females across
three small communities.
More recently, Clough and colleagues have undertaken work in remote Cape York
communities in Northern Queensland (Bohanna & Clough, 2012; Graham & Clough,
2018). They identified very high rates of cannabis use, with 66% of males and 31% of
females interviewed from a single community being current users in one study, and 55%
of males and 30% of females in another study which collected data from three
communities (Graham & Clough, 2018). Furthermore, in the initial study only 22% of
males and 39% of females had never used cannabis (Bohanna & Clough, 2012). The
research conducted in Northern Australia is both community and time specific and
consequently not generalisable. However, the data do demonstrate the extent and high
prevalence of cannabis use which can occur in some communities. Considering this data,
a number of commentators have argued that cannabis use is endemic in remote Northern
Australian communities and of significant cause for concern (Bohanna & Clough, 2012;
Graham 2018; Lee et al., 2009) (Robertson & Dowie, 2008).
Despite the lack of detailed research focused on cannabis outside of remote
communities in Northern Australia, research among vulnerable populations has identified
high levels of cannabis use and are worthy of discussion. A number of studies have
highlighted the high rates of cannabis use among those involved with the criminal justice
system. In examining drug use among incarcerated males, Doyle and colleagues
identified that Aboriginal prisoners were more likely to have used cannabis at least daily
prior to incarceration (46%) compared to non-Aboriginal prisoners (37%) (Doyle et al.,
2015). Similarly, Heffernan and colleagues identified that among a sample of 419
Aboriginal prisoners in Queensland, cannabis dependence was noted in 26% of females
and 20% of males (Heffernan et al., 2016). Further, Steele and others found that among
justice involved young people (aged 14 – 17 years), that 79% of young people had ever
used cannabis and 70% had used in the previous year (Steele et al., 2021). High levels of
cannabis use have also been noted among police detainees as part of the Drug Use
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Monitoring in Australia (DUMA) program; the two most common drugs detected for
Aboriginal detainees were cannabis (ranging from 52% in Sydney to 72% in Perth) and
methamphetamine (ranging from 28% in Adelaide to 65% in Perth) (Australian Institute of
Health and Welfare, 2020a).
Considering the potential for cannabis to cause harm for unborn children, the use of
cannabis, and high levels of cannabis and tobacco co-use, pregnant women are a
population worthy of consideration. Brown and others (Brown et al., 2019; Brown et al.,
2016) found that 21% of pregnant women in a birth study of 344 mothers of Aboriginal
babies had used cannabis during pregnancy. The study found that maternal cannabis use
was related to low birth weight and preterm birth when controlling for other variables
(Brown et al., 2016). The adjusted mean difference (controlled for health and wellbeing
variables) and in birth weight between mothers who used cannabis and those who
smoked neither cannabis nor tobacco was 419g (Brown et al., 2016). Similarly, in a
cross-sectional sample of 257 pregnant Aboriginal women Passey and colleagues
identified that 15% of participants smoked cannabis. They noted the co-occurrence of
alcohol, tobacco and cannabis use (Passey et al., 2014), and although almost half of the
participants did not smoke cannabis, drink alcohol nor smoke tobacco during pregnancy,
there was a high risk cohort that used all three (Passey et al., 2014).
Finally, the perceptions of health workers on the rates of cannabis use provide useful
information. As part of a project to pilot cannabis screening and brief intervention, staff of
six Aboriginal Community Controlled Health Services were asked about their perceptions
of cannabis in the local community – 95% of participants reported use was ‘common’ or
‘very common’ (Butt et al., 2009). Thirty percent reported ‘most’ of their patient’s used
cannabis, with only 50% reporting either ‘a quarter’ or ‘a few’. The theme that cannabis
use was normalised was consistent in focus groups with health care staff (Butt et al.,
2009).
Despite the difficulty in identifying high quality epidemiological data related to
cannabis use, it is clear from the existing research that cannabis use is concerningly high
among Aboriginal people. Indeed, researchers and community consultations from
Northern Australia and Aboriginal health staff in both urban and rural communities have
raised concerns about the high prevalence and normalisation of cannabis use. Despite
these high rates and some concern regarding public health implications of high rates of
use, cannabis use has attracted little concern among the health community. In summary,
while cannabis has rarely been the focus of research it has been identified in a number of
studies in which it becomes part of a broader cluster of concerns which arise from
inequality and contribute to ill-health and decreased social and emotional wellbeing.

Patterns of cannabis use and social contexts of cannabis use
Course of cannabis use
Considering that the international data regarding the harms associated with cannabis
being exacerbated when use commences at a young age (Passey et al., 2014), it is
important to understand the age of initiation and the context of use in order develop
successful prevention and health promotion strategies. Detailed qualitative and
descriptive data regarding both cannabis initiation and the lifetime course of cannabis use
is lacking which prevents a nuanced discussion. What we do know from research to date
is that cannabis initiation is common in adolescence. As described above, research data
from ASSAD demonstrates that cannabis use initiation starts in school for some young
Aboriginal people; 19% of Aboriginal students aged 12-15 years reported they had used
cannabis, and 42% of 16 -17 years old’s reported cannabis use (Heris et al., 2020).
Similarly, Clough identified that cannabis use commences at a young age in some remote
Aboriginal communities in the NT (Clough, 2005; Clough et al., 2005). In Bohanna and
Clough’s community sample in Northern Queensland, the mean age of cannabis initiation
was 15.7 years, and community consultation in North Queensland identified that
communities are becoming concerned at the young age at which people are starting to
use cannabis (Robertson & Dowie, 2008). These findings are in contrast to that of a
sample of vulnerable young people – those involved with the justice system – who had a
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mean age of cannabis initiation of 13 years with a range 5 years to 17 years (Steele et
al., 2021). Considering the higher risk of harms associated with cannabis use at a young
age these findings are concerning. The latency between age of initiation and onset of
regular use, and the factors predicting transition to regular use are lacking in the
literature.
Understanding the course of cannabis use, in particular patterns of cessation across
the lifespan, is significant in the development of interventions which prevent harms
associated with cannabis use. International literature has identified that progression from
cannabis use to dependence is related to frequency and quantity of use, tobacco use,
alcohol use and peer use (Cerda et al., 2018; Chan et al., 2021; Copeland & Pokorski,
2016; Copeland et al.,2017; Degenhardt et al., 2001; Hall, 2014; Taylor et al., 2002). Very
limited research regarding the course of cannabis use has been undertaken with
Aboriginal people. Only one longitudinal study has been published to date. Lee and
others conducted a five-year longitudinal study with 83 people from three remote Arnhem
Land communities, they found that 76% of male and 54% of female cannabis users at
baseline were still using cannabis at follow-up (Lee et al., 2009). The only significant
predictors of cannabis use at follow-up were being male and a history of petrol sniffing.
Lee’s findings suggested that within this specific cohort cannabis use was persistent with
dependence symptoms commonplace (Lee et al., 2009).
Several studies have investigated cannabis cessation among Aboriginal adults.
Jacups and others (Jacups & Rogerson, 2015) investigated predictors of cannabis
cessation among incarcerated Aboriginal males from non-urban communities of origin.
Not surprisingly, non-voluntary cessation on incarceration was the primary reason
identified by participants, other influences included social reasons (having a new child,
family responsibilities and changes in peers), health and wellbeing (in particular paranoia)
and employment reasons. They also examined self-reported factors which increased
cannabis use and these included stress (including relief of physical pain and emotional
pain), social influences (peers and family influence) and boredom (Jacups & Rogerson,
2015). The research in Cape York has discussed cannabis cessation among Aboriginal
people; Bohanna and Clough reported that among community respondents 31% of
females and 12% of males were former cannabis users, suggesting successful
discontinuation of cannabis use, furthermore, a significant proportion of current users
(76%) reported a desire to quit (Bohanna & Clough, 2012). Key reasons for quitting
cannabis or wanting to quit cannabis were consistent with the findings of Jacups and
included: family, mental health, no longer being interested, financial concerns and starting
a new job (Bohanna & Clough, 2012). There is limited data from which to explore the
course of cannabis use, particularly among Aboriginal people living in urban areas.
Existing results do suggest that cannabis cessation can be linked to social factors which
are consistent with the international literature.
Patterns and social contexts of cannabis use
As above there is limited detailed descriptive or qualitative data regarding patterns and
social contexts of cannabis use among Aboriginal Australians, and much of the existing
data is not generalisable. Understanding patterns of cannabis use requires an
understanding of quantity and frequency of use; there has not been a uniform approach
to this in the research, and most studies are limited to lifetime and past year severity.
Lifetime or past year use of cannabis does not indicate cannabis use that may result in
harm. Some data exists in which patterns of cannabis use are reported and tend to reveal
heavy prevalence use among those who use cannabis. In studies conducted in Northern
Australia, 48% of current cannabis users were identified as being heavy users (defined as
using more than 6 cones per session at least weekly; in the larger Cape York study
across three communities), (Graham 2018), similarly Lee and colleagues found 49% of
participants in three Arnhem communities (aged 13- 42 years) reported smoking more
than six cones per day (Kylie Lee et al., 2008). High rates of harmful use have been
identified in other studies. For example, Passey noted that among pregnant Aboriginal
women currently smoking, the mean quantity of cannabis consumed per occasion was
seven cones or joints per day (Passey et al., 2014). Among incarcerated males from nonremote areas, an average daily consumption of 12.3 cones per day was reported (Jacups
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& Rogerson, 2015), and over 30% of justice-involved young people reported using
cannabis more than once per day (Steele et al., 2021).
Lee and colleagues reflected that the rates of heavy use noted in Arnhem Land were
consistent with observations from alcohol research which suggests a polarisation of
users, with most Aboriginal people being heavy users or abstainers (Lee et al., 2009).
Focus group discussions with Aboriginal health workforce health workers have reported
anecdotal evidence that heavy episodic cannabis use (inconsistent ‘binge’ use) was
common among young people (Butt et al., 2009). Thus, the limited data available
emphasises that risky patterns of cannabis consumption exist among Aboriginal cannabis
users, particularly among vulnerable populations. Further research is required to
determine a clearer picture of differing patterns of cannabis use.
There has been little discussion regarding cannabis use behaviour in the literature,
however research suggests that the most common mode of cannabis use is smoking and
the use of bongs is the preferred smoking method (Clough, D'Abbs, et al., 2004; Graham
2018). Social contexts, such as typical situations and locations for cannabis use, and the
makeup of social situations in which cannabis is used (e.g. intergenerational, peer, family,
mixed gender) have not been adequately described in the literature and in depth
qualitative research into the social context of cannabis use is indicated.

Polydrug use
Cannabis is often used alongside other drugs either on the same occasion or by the
same person on different occasions. As commented by a participant in health worker
focus groups, ‘cannabis is the other drug in polydrug use’ (Butt et al., 2009). The
clustering of alcohol, tobacco and cannabis consumption are widely documented in the
international literature and among Aboriginal people (Brown et al., 2016; Heris et al.,
2020). Clough and colleagues reported that current users of cannabis were more likely to
be heavy alcohol drinkers and tobacco smokers than non-users (Clough, D'Abbs, et al.,
2004; Clough et al., 2005). Interestingly, an analysis of the ASSAD data shows that
Aboriginal school students who smoked tobacco were more likely to also smoke
cannabis, however were not more likely to use alcohol (Heris et al., 2020).
The relationship between cannabis and tobacco is of particular concern with high
global rates of co-use (Hindocha et al., 2016). Consistent with the international literature,
Aboriginal people who use cannabis mostly smoke cannabis mixed with tobacco and are
more likely to smoke tobacco cigarettes in greater numbers than those who do not use
cannabis (Thomas et al., 2018). A recent study investigating the co-use of cannabis and
tobacco among Aboriginal adults who identify as smokers found that 81% of cannabis
smokers also smoked tobacco (Butt, 2020). Co-use of tobacco with cannabis is the norm
rather than the exception (Butt, 2020; Thomas et al., 2018) and presents significant
health effects, including increasing the risk of dependence on both substances (Patton et
al., 2005; Ramo et al., 2012; Tucker, 2019).
Consistent with the ‘gateway’ phenomenon, cannabis is potentially a risk factor for
other illicit drug use (Hall & Lynskey, 2009), and indeed cannabis use has been shown to
be high in the general Australian community (Australian Institute of Health and Welfare,
2021b) and among Aboriginal illicit drug users (Passey et al., 2014). For example, in a
large national survey on methamphetamine use among Aboriginal and non-Indigenous
people, 57% of the Aboriginal participants who used methamphetamine also used
cannabis in the previous month (Reilly et al., 2020). Important to note is that within this
study there was no difference in cannabis use prevalence between Aboriginal and nonIndigenous participants who used methamphetamine (Reilly et al., 2020).

Risk and protective factors
A small number of studies to date have identified risk and protective factors in relation to
cannabis use. In a recent strengths based study Graham and colleagues (Graham et al.,
2021) investigated the factors associated with never having used cannabis in a sample of
301 (64% female) Aboriginal young people (aged 16-24 years) drawn from a larger study;
58% of the sample had never used cannabis. They found that never having used
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cannabis was associated with other positive health and wellbeing indicators such as
never having drunk alcohol, never smoking cigarettes, never being diagnosed with
anxiety, having low levels of psychological distress and being a parent or caring for a
child (Graham et al., 2021). In another study among male non-urban incarcerated
Aboriginal males current cannabis users were more likely to have left school earlier and
been involved with the justice system as a juvenile than those who had never used
cannabis or were ex-cannabis users (Jacups & Rogerson, 2015). Taken together these
results emphasise that cannabis use is part of a broader pattern of health and wellbeing.
A number of studies have investigated the risk and protective factors associated with
drug use among Aboriginal people. A recent systematic review of the literature (Snijder et
al., 2020) has identified individual-level, relationship-level, community level, societal level,
and culturally distinct factors which were then used to develop an ecological model of
drug and alcohol use and related harms. Individual level factors included low socioeconomic status, high psychological distress, polydrug use and being male. Relationship
level risk factors were peer pressure, family or partner drug use, with protective factors
being supportive environments and availability of positive role models. The community
level risk factor was availability of drug use. Culturally distinct factors included cultural
connection as a protective factor but cultural obligation around sharing as a risk factor
(Snijder et al., 2020). The authors identified intergenerational trauma resulting from
government policies as a societal risk factor for AOD use. This review demonstrates the
importance of considering cannabis, and other drug use, within broader ecological
contexts (Snijder et al., 2020).

Extent of cannabis related harms
There is a considerable lack of literature detailing the degree to which cannabis related
harms are experienced in the Aboriginal community, however the lack of research
attention does not equate to lack of harms. As concluded in the Little children are sacred:
report of the Northern Territory Board of Inquiry into the protection of Aboriginal children
from sexual abuse:
Cannabis has been a significant issue identified at nearly every community meeting it
has held. Participants in these meetings identified that cannabis is present in their
community and they believe it is having negative effects on community and family life
and, in particular, consequential effects on the care and protection of children
(Anderson & Wild, 2007, pp. 173).
Similarly, research within Aboriginal community controlled primary health care
identified that health staff regard cannabis use as causing considerable harm (Butt et al.,
2014). The prevalence data presented above notes patterns of use which are consistent
with the likelihood of experiencing harms – use at a young age and high levels of use –
thus it is likely that harms are experienced by Aboriginal people who use cannabis.
Specific individual level harms have been noted in the literature pertaining to communities
in Northern Australia these include high rates of dependence (Graham, 2018), mental
health concerns including anger and irritability, thoughts of suicide/self-harm, paranoia,
depression, memory problems (Bohanna & Clough, 2012), and increased risk of violence
(Lee et al., 2015). Further anecdotal evidence from community members has expressed
concern that cannabis use may be a trigger for relationship problems, family violence,
suicide, and psychosis (Anderson & Wild, 2007; Lee et al., 2007; Putt & Delahunty,
2006).
In addition to the direct effects of cannabis, it is likely that cannabis plays a role in
exacerbating and maintaining existing health and wellbeing problems at a community
level. Several papers have reported concerns that Indigenous community members have
about the broader effects of cannabis (Clough, D'Abbs, et al., 2004; K. Lee et al., 2007;
Putt & Delahunty, 2006)( Clough et al., 2006; Robertson & Dowie, 2008), these include:
the high proportion of income spent on cannabis, community violence related to supply in
remote communities, the impact of big dealers on community, child neglect, sexual
exploitation, declining participation in community life, and reduced participation in
education and training. Community level concerns such as high rates of cash spent on
cannabis and normalised use have also been noted (Clough, Cairney, et al., 2004;
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Clough, Cairney, et al., 2002; Clough, D'Abbs, et al., 2004; Clough et al., 2005; Clough et
al., 2006; Graham, 2018). For example, in research conducted in three northern
Queensland communities researchers identified that across three communities up to
$AUD14,200/week was spent on cannabis, which equated to 9% of community members’
total income (Graham, 2018). Withdrawal from education (Steele et al., 2021) and
engagement in the criminal justice system (Clough et al., 2006) have also been noted as
harms associated with use.
There is a lack of research documenting the prevalence of harms associated with
cannabis use; however, some studies have shown some clear harms to health and
wellbeing. Jacups used the Marijuana Problems Inventory among their sample of 101
non-urban incarcerated Aboriginal males (Jacups & Rogerson, 2015). They identified that
among cannabis users 51% identified experiences of anxiety and paranoia, 52%
identified forgetting to care about themselves (not eating right, not participating in family
activities etc.), 30% feeling down or sad with no good reason, 48% reported not engaging
in valued activities because of using cannabis and 61% reported getting trouble with
police in relation to use (Jacups & Rogerson, 2015). It is relevant to note that 74% of
participants reported smoking cannabis first thing in the morning before breakfast – a
practice consistent with dependence (Jacups & Rogerson, 2015).
Cannabis dependence has been noted in a number of additional studies suggesting
that the extent of harms related to dependence is significant. In a sample of Aboriginal
people in custody, Heffernan identified that 95% of those using cannabis met criteria for
cannabis dependence (Heffernan et al., 2016). Similarly, in Cape York, Bohanna and
Clough identified 68% of participants who used cannabis at least weekly met criteria of
dependence using the severity of dependence scale (Bohanna & Clough, 2012). Among
the longitudinal sample followed by Lee and others they found that 88% percent of
cannabis users reported three or more symptoms of dependence; most commonly
experienced were unsuccessful attempts to control use, withdrawal symptoms and time
spent obtaining cannabis or recovering from its effects (Lee et al., 2009). Findings from
these studies, although not generalisable, indicate that concerningly high rates of
cannabis use dependence can exist in some Aboriginal communities and at-risk cohorts.
The presentation to treatment for cannabis related harm can also provide some
indication of the extent of harms experienced by Aboriginal people. Among people
seeking treatment for AOD use, cannabis use is high, indeed the Alcohol and Other
Drugs Minimum Data Set (AODT MDS) 2018-2019 highlights that Aboriginal people are
more likely to receive drug treatment for cannabis use than non-Indigenous people
(Australian Institute of Health and Welfare, 2021a). Further findings from the AODT MDS
suggest that almost one in five clients seeking treatment for own use of cannabis were
Aboriginal (Australian Institute of Health and Welfare, 2021a). Trends in the AODT MDS
also suggest that there are increasing numbers of treatment episodes for cannabis use
for Aboriginal people; increasing from 4,397 closed episodes in 2010/11 to 7,775 in
2019/20 (Australian Institute of Health and Welfare, 2021a). To put this data in to context
a file audit of 2,326 admissions to an Aboriginal Community Controlled Rehabilitation
facility identified cannabis as the primary drug of concern for 12% of patients (James et
al., 2022), suggesting that despite high prevalence of use, and potentially high rates of
cannabis dependence, it is a primary drug of concern for only a small proportion of those
seeking treatment. This gap between rates of dependence and prevalence and treatment
seeking warrants further research to identify why people who use cannabis may not be
accessing treatment services.
Cannabis use is a risk factor for the development of mental health disorders and
potentially suicide (Campeny et al., 2020; Measey et al., 2006). The extent of mental
health harms as a result of cannabis use among Aboriginal people is not possible to
quantify due to the lack of longitudinal research which can adequately account for
confounding variables. That said, high rates of comorbidity of cannabis use and mental
health disorders have been noted in the literature. Those who use cannabis are more
likely to experience depression (Jacups & Rogerson, 2015; Jamieson et al., 2011; Lee et
al., 2008), anxiety (Bohanna & Clough, 2012; Jacups & Rogerson, 2015) and psychosis
(Clough et al., 2006). Of note in the study by Lee, individuals who used cannabis heavily
(six or more cones per day) were four times more likely to report moderate to severe
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depressive symptoms (after adjustment for age, sex and other substance use) (Lee et al.,
2008). At a community level Clough found that mental health presentations increased as
cannabis use increased in a number of small communities in Arnhem Land (Clough,
D'Abbs, et al., 2004; Clough et al., 2005). Mental health sector data also reveals
important insights. In a data linkage study examining treated cases of psychosis in Cape
York, cannabis use was associated with 60-70% of psychosis cases in the Aboriginal
population from 2003 to 2015 (Gynther et al., 2019).
The Western Australian Aboriginal Child Health Survey (WAACHS), which is a large
scale research project into the health of Aboriginal children in Western Australia,
collected social and emotional wellbeing data from 3,993 children aged 4 to 17 years.
Cannabis use was included in the research (Zubrick et al., 2005). The results
demonstrate the intersection of cannabis use with overall social and emotional wellbeing.
Daily cannabis use was associated with risk of clinically significant emotional or
behavioural difficulties. Over one quarter (29%) of young people who used cannabis daily
were at risk of clinically significant emotional or behavioural difficulties compared with
8.7% of young people who had never used cannabis, this finding was stronger among
females. The proportion of young females at high risk of significant emotional or
behavioural difficulties increased with increasing frequency of cannabis use (Zubrick et
al., 2005).
Finally, evidence of the extent of cannabis related mental health harms can be drawn
from emergency department data which has previously identified that Aboriginal people
are five times more likely to be hospitalised for cannabis-related mental and behavioural
disorders than non-Indigenous people (Australian Institute of Health and Welfare, 2011)
although more recent data is required. In considering AOD use disorders and mental
health comorbidities more generally, Aboriginal people who experience comorbid
disorders are likely to have poorer outcomes than those experiencing a mental health or
AOD use disorder alone (Wilkes et al., 2010). Comorbidity can lead to severe and wide
ranging negative outcomes, including poor health, diminished social networks,
unemployment, and financial instability; and impacts on capacity to care for self and
dependents (Lee et al., 2013).
In light of international evidence that cannabis use is associated with an increased
risk of suicide (Campeny et al., 2020; Measey et al., 2006) and concerning suicide rates
among Aboriginal people (Measey et al., 2006; Soole et al., 2014), it is important to
consider the potential role of cannabis use in suicide and suicidal ideation among
Aboriginal people (Measey et al., 2006). Increased suicide risk has been noted among
individuals with an AOD use history; for example, Aboriginal people in custody with an
AOD use disorder are more likely to have experienced suicidal thoughts and ideation
than those who do not use substances (Heffernan et al., 2016). With respect to cannabis
use specifically, for participants in remote Arnhem communities participating in the
research by Clough and colleagues, those using cannabis at baseline and follow-up in a
three year study were more likely to report suicidal ideation (Clough et al., 2006).
Similarly, in the WAACHS, suicidal ideation in the 12 months prior to the survey was
significantly lower in young people who had never used cannabis (12%) compared to
those who had used in the last year. The proportion having suicidal thoughts within the
last year was 25%, 32% and 29% of those using marijuana ‘less than monthly’, ‘about
weekly’ and ‘daily’ respectively (Zubrick et al., 2005).
Various reviews of deaths by suicide have identified cannabis in post-mortem
toxicology and coronial inquest suggest an association between cannabis use and
suicide. In the coronial inquest into the deaths of 13 young people by suicide in the
Kimberly in Western Australia, the Coroner noted that three cases had cannabis
derivatives in their blood after death (Fogliani, 2019), with recommendations from the
inquest noting the need for increased AOD treatment services. In a review of suicide
deaths in Western Australia in 2000 it was noted that 20% of males and 11% of females
recorded positive toxicology for cannabis; there was no significant difference between
Aboriginal and non-Indigenous people (Hillman et al., 2000). Finally in other reviews of
suicide deaths, in the Northern Territory cannabis was formally detected in 31% of
Indigenous and 20% of non-Indigenous cases, and noted in a further 17% and 11% of
case reports, respectively (Kuipers et al., 2012). Cannabis was identified as having a role
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in the suicide of 30% of young Aboriginal suicide cases and 20% of older adult suicides
using thematic analysis of cases (Hanssens, 2007). A number of authors have concluded
that much like alcohol, high cannabis use is associated with increased suicidal ideation in
Aboriginal communities (Kuipers et al., 2012) (Clough et al., 2006).
Considering the legal status of cannabis in Australia engagement in the justice
system is a potential harm of recreational use. Arrests for personal cannabis use can
result in wide-ranging and long-lasting impacts on an individual, their family and
community. Despite this, there is scant publicly available data from which to examine
engagement in the justice system arising from cannabis use among Aboriginal people
and its impacts. The latest national population-based arrest data reported by the
Australian Crime Commission demonstrate that the majority of arrests are for personal
recreational use. There were 71,151 cannabis arrests in 2018-2019; 91% were due to
personal possession or use, with supply-type offences such as importation, trafficking,
selling, cultivation and manufacture making up only 9% (Australian Criminal Intelligence
Commission, 2020).
Not surprisingly, there is concern that the legal status of cannabis may put Aboriginal
people at risk of engagement with the justice system. As highlighted by the Victorian
Aboriginal Legal Service Submission to the Victorian Inquiry into Use of Cannabis in
Victoria in 2020 – incarceration as a result of personal cannabis use contributes to
continued overrepresentation of vulnerable communities in the justice system (Victorian
Aboriginal Legal Service, 2020). These concerns are well founded considering data
revealed by The Guardian Newspaper which highlighted that in NSW in 2019 Aboriginal
people were more likely to be pursued in court for cannabis related offences than nonIndigenous people. The Guardian reported:
82.55% of all Indigenous people found with a non-indictable quantity of cannabis
were pursued through the courts, compared with only 52.29% of non-Indigenous
people, and non-Indigenous people were four times more likely to receive a caution
(McGowen & Knaus, 2020).
This data suggests that Aboriginal people who use cannabis are at a greater risk of
incarceration than non-Aboriginal people and raises concerns regarding the unequal
application of cannabis related laws. Increased rates of incarceration place Aboriginal
people who use cannabis at risk of experiencing the range of negative consequences
associated with incarceration – including challenges in finding employment and housing
post release, stigma, and the negative mental health effects of incarceration (e.g. Wilson
et al., 2017). Given the apparent unequal application of cannabis laws and the
experience of overpolicing described by Aboriginal people (e.g. Wilson et al., 2017)
further examination of the impact of cannabis related policing and engagement in the
justice system for Aboriginal people is warranted.

Prevention and treatment for cannabis related harms
Unsurprisingly, given the lack of overall research into cannabis use among Aboriginal
people there is a lack of evidence regarding effective responses to harmful cannabis use
among Aboriginal people. As stated in the Little children are sacred: report of the
Northern Territory Board of Inquiry into the protection of Aboriginal children from sexual
abuse:
Literature on how best to respond to the problems of illicit drug use, in particular
cannabis, by Aboriginal people generally, and young people in remote communities
specifically, was difficult to locate. However, the reports and research that do exist
identify the need for a number of strategies that will address control of supply,
demand management, harm reduction, early intervention and treatment (Anderson &
Wild, 2007, p. 228).
Given the lack of evidence, the summary below considers both cannabis specific and
broader relevant best practice approaches to responding to AOD related harm for
Aboriginal people. Harmful drug use is multi causal, it requires a range of complex
approaches (Gray & Wilkes, 2010b). These approaches can be thought of as falling
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under the three pillars of harm reduction, demand reduction and supply reduction within
the National Drug Strategy (Commonwealth of Australia (Department of Health), 2017).
Within these pillars approaches to harmful cannabis use need to include preventing
uptake of cannabis use, promoting and supporting cessation among heavy users, supply
reduction measures, addressing wellbeing and the social determinants of health at a
community and individual level and supporting the Aboriginal workforce. All these steps
need to be grounded in the principles of best practice in working with Aboriginal people,
requiring Aboriginal self-determination, cultural safety and security, and being trauma
informed (Coffin, 2007; McGough et al., 2018; National Indigenous Drug and Alcohol
Committee, 2014).
In general, harmful cannabis use is best addressed from within existing structures
and services rather than requiring specific services. In conceptualising the lack of
evidence around cannabis interventions it is useful to consider again the comments of
Lee and colleagues (Lee et al., 2007) who highlighted that although cannabis use rates
are high, it is a neglected topic, and the comments of Butt and others, including the
Victorian Aboriginal Legal Service, (Butt et al., 2010; Butt et al., 2014; Victorian Aboriginal
Legal Service, 2020) who argue that cannabis use belongs on the health agenda and
requires a health response. After summarising the principles of best practice below, the
review will cover best practice approaches in harm and demand reduction, covering
cannabis treatment separately. Policing responses in relation to supply reduction are
beyond the scope of this review.
Principles of best practice
Despite a lack of evidence based interventions for cannabis use, there is a growing
understanding of what is needed in the delivery of AOD services to Aboriginal people
(Gray & Wilkes, 2010b) (Gray et al., 2014). This includes factors related to cultural safety
of interventions; the need for Aboriginal leadership and holistic and integrated service
delivery; interventions that are strengths based, family focused, trauma informed and are
appropriately planned, resourced and evaluated using culturally informed methodologies.
These principles of best practice include:
Focus on social and emotional wellbeing
Appropriate responses to cannabis must occur with the recognition that drug use is
connected to a holistic sense of health and wellbeing. Where health refers to the broader
social, emotional and cultural wellbeing of individuals and communities (National
Indigenous Drug and Alcohol Committee, 2014) and includes connection to land, culture,
spirituality, ancestry, family and community (Gray & Wilkes, 2010b; National Indigenous
Drug and Alcohol Committee, 2014; Strong Spirit Strong Mind, 2021).
Implied in this is the need to involve families and communities in any drug treatment,
and in particular provide treatment and support to those supporting family members who
may use drugs (Snijder & Kershaw, 2019). To address social and emotional wellbeing
there is the need to provide holistic services that can support people who use cannabis to
develop in other life areas. This requires integrated and supported treatment for those
high levels of multiple need (Gray & Wilkes, 2010b).
Cultural determination, ownership and leadership
AOD treatment requires community ownership and consultation, without this,
interventions risk being colonising forces (Percival et al., 2018). Further, partnerships,
community consultation and Aboriginal ownership are required at all levels of service
design, delivery and evaluation (Gray et al., 2014). The role of the Aboriginal Community
Controlled Health sector is vital in ensuring that the needs of the community can be
properly addressed (Gray et al., 2014).
Cultural security and cultural responsivity
Culturally secure services for Aboriginal people are integral to best practice approaches
and need to be embedded in Aboriginal ways of knowing and doing (Dudgeon & Ugle,
2014; Dudgeon et al., 2014b). Indeed, culturally safe approaches are acknowledged to
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result in better outcomes (Gray et al., 2014). Cultural security ensures that cultural needs
are included in policies and practices and cultural values are incorporated into the design,
delivery and evaluation of services (Australian Human Rights Commission, 2011;
Dudgeon et al., 2014b). This requires effort in upskilling both non-Indigenous practitioners
and policy makers, but also ensuring that the Aboriginal workforce is adequately
supported and their expertise acknowledged and appropriately renumerated. Further, it
requires significant long term resourcing to support an increase in the number Aboriginal
people in professional health workforce (Westerman, 2021).
Appropriate resourcing
Reviews of the Aboriginal AOD treatment sector have repeatedly highlighted the need for
appropriate planning and resourcing of Aboriginal AOD interventions and recognised the
harm of underfunding and non-recurrent funding and fragmented services (Gray et al.,
2014). Service providers and intervention approaches need to be set up to succeed with
adequate and continued funding and evaluation (Gray et al., 2014) and sufficient focus on
implementation (Butt et al., 2014).

Demand reduction and harm reduction
Health promotion, education and awareness raising
Given the prevalence of heavy cannabis use detailed above, there is a clear need for health
promotion materials to support the prevention of cannabis related harm and informed decision
making. That said, it is important to consider that cannabis use may not be a priority harm for
most communities (compared to alcohol and tobacco, for example) and as a consequence
approaches need to fit within community needs and wishes (Butt et al., 2014). Furthermore,
community health literacy regarding the harms of cannabis use is arguably low (Lee et al.,
2008). Consequently, Lee and colleagues argued that investments in locally developed
models to improve health literacy around cannabis use and specifically to acquaint young
people with harms related to cannabis misuse are clear priorities, and that these must be
developed and disseminated in collaboration with communities (Lee et al., 2008).
The National Cannabis Prevention and Information Centre (NCPIC), which was
funded between 2007 and 2016, produced a number of cannabis specific resources for
Aboriginal communities however since its defunding there has been diminished national
level approaches to cannabis related harms. NCPIC undertook a number of awareness
raising art and music projects which used the arts to develop representations of
communities’ and artists’ beliefs about cannabis and its use (Howard et al., 2012). The
goal of this project was to raise awareness in the particular communities of cannabis, its
use and any associated and undesired consequences. The works tended to reflect how
cannabis entered a community, stayed and became problematic and promoted visions of
community without cannabis (Howard et al., 2012).
In addition to the awareness raising projects, NCPIC funded the development of a
primary health care level intervention, the Could it be the Gunja? Project, which also
produced a range of health promotion resources (Butt et al., 2014). These included
posters and pamphlets which were developed in community partnership, focused on
harms of concern to communities and piloted prior to dissemination. In line with
community consultation feedback, the resources aimed to stay away from ‘no’ messages
and instead aimed to provide information about cannabis in an open, non-judgemental
and informative way (Butt et al., 2014). The dissemination of materials was linked to
upskilling of primary health care staff in responding to cannabis use (Butt et al., 2014).
Awareness raising has value in not just providing people with information from which to
make an informed choice about cannabis use but also because it provides an opportunity to
shift favourable attitudes about cannabis which may precede and predict use (Fishbein &
Ajzen, 2009). Another example of cannabis awareness raising and health promotion comes
from Lee and colleagues (Lee et al., 2008) who sought to disseminate the findings of their
research into cannabis use in Arnhem Land using pictorial and local language graphics to
convey the concepts and meanings that arose from their research. Evaluation
demonstrated widespread satisfaction with the resources and increased understanding of
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the impacts of cannabis use. The authors noted the importance and value of community
partnership and in particular ensuring local leadership was listened and responded to (Lee
et al., 2008).
The resources and approaches above are all grounded in community ownership and
storytelling, which is consistent with best practice, however none are currently funded or
ongoing projects. A number of other cannabis information, awareness raising and health
promotion materials exist with a number being developed and led by Aboriginal
organisations and teams, for example the Strong Spirit Strong Mind Gunja pamphlets
developed by WA Mental Health Commission (Western Australia Mental Health
Commission, 2020), however evaluation of these resources and their dissemination is
lacking. There is a need for culturally appropriate and culturally driven health promotion
(Percival et al., 2018) on harmful cannabis use. Over the years considerable investment
has been made in health promotion, yet efficacy is limited by poor evaluation resourcing
(O'Donoghue et al., 2014) and limited commitment to the implementation of resources
into practice (Butt et al., 2014; Percival et al., 2018). Effective health promotion needs to
strengthen capacity, tailor resources for diverse groups and have effective reciprocal
communication (Percival et al., 2018). O'Donoghue and colleagues (O'Donoghue et al.,
2014) argue that best practice in the development of health promotion materials requires
planning, targeting, partnerships and evaluation – leading back into planning with
community participation integral at each step in the cycle. Further effective health
promotion requires respecting leadership within the Aboriginal community to develop
relevant messages (Pyett et al., 2008). New approaches would do well to focus on social
media and specific marketing for the intended audience, which has been identified as a
valuable approach in the reduction of tobacco (Colonna et al., 2020), alcohol (Gray et al.,
2018) and methamphetamine related harm (Snijder & Kershaw, 2019).
A key component of prevention approaches are school-based interventions (Teesson
et al.,2012). These interventions include universal programs (aimed at all children) and
targeted interventions (aimed at high-risk individuals and groups). More recent approaches
to prevention focus on harm minimisation messaging and increasing the capacity of young
people to make informed choices about drugs as opposed to abstinence-based approaches
(Clare et al., 2011). Given the high prevalence of cannabis use and the potential for
misinformation, school-based education programs are a vital component of harm
prevention. A detailed review of school-based programs is beyond the scope of the current
paper, however it is important to recognise their importance in the prevention of cannabis
related harm (Clare Newton et al., 2011), yet there is a dearth of evidence to support the
efficacy of school-based education programs for Aboriginal young people (Snijder et al.,
2020). The most commonly utilised school-based programs which target cannabis use in
Australia are the Climate Schools program (Snijder et al., 2020) and Positive Choices Drug
and Alcohol Information (Positive Choices, 2017; Stapinski et al., 2017). Of note, one recent
school-based intervention focusing on both well-being and AOD use has been designed
specifically for Aboriginal young people – The Strong and Deadly Futures Program
(Stapinski et al., 2022). Snijder and colleagues (Snijder et al., 2021) describe the Strong
and Deadly Futures program as a six-lesson, curriculum-aligned wellbeing and substance
use prevention program utilising a story-based structure that was designed for, and with
Aboriginal young people. The program includes three core approaches; firstly, combining
effective components of mainstream prevention with cultural elements, highlighting
Aboriginal cultural strengths; secondly avoiding stigma and focusing on the strengths of
cultural diversity by including both Aboriginal and non-Indigenous students; and thirdly
using digital technology to enhance engagement. Strong and Deadly Futures is currently
being trialled, however an early pilot study identified that it had good feasibility and
acceptability for both students and staff and shows promise as an option for school-based
prevention for cannabis related harms (Routledge et al., 2022).
Community interventions
Localised approaches to reducing drug related harm are worthy of attention, these
approaches need to be based on community strengths as well as having effective and
integrated strategies (Snijder & Kershaw, 2019). Only one whole of community response
to cannabis has been noted in the literature; the Weed it Out project which took place in
Cape York and the Torres Strait in Queensland as a partnership between peak Aboriginal
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and Torres Strait Islander community representatives, James Cook University and the
Queensland Police (Robertson & Dowie, 2008). The project focused on community led
demand reduction activities, awareness raising (around mental health effects and legal
consequences) and supply reduction priorities (Robertson & Dowie, 2008) with the aim of
changing community attitudes to cannabis use and reducing supply (Howard et al., 2012).
While other programs have not been documented to date, community wide approaches
have demonstrated usefulness in responding to other drugs such as methamphetamine
(Snijder & Kershaw, 2019) and alcohol. A review and further development of whole of
community responses to cannabis use are warranted.
Screening and brief intervention in primary health and antenatal health
Primary health care services and maternal health services are ideally positioned to
provide health promotion, and also screening and brief intervention (with referral if
necessary) for those experiencing or at risk of experiencing substance related harm
(Anderson, 2007; Copeland et al., 2001; Gray et al., 2014; Moyer et al., 2001). Screening
and brief intervention for tobacco and alcohol use have been widely trialled in Aboriginal
health settings (Brady et al., 2002; Clifford & Shakeshaft, 2011; Clifford, & Shakeshaft,
2010). Screening and brief intervention identifies if someone uses cannabis, if so at what
level of harm and can identify potential opportunities for referral or health advice.
Screening and brief intervention approaches are valuable as they are low cost to deliver
and can provide useful assistance to those who need minimal help while providing a
referral pathway for those who require more intensive service provision. Brief
interventions are also guided by an individual’s motivation to change and as such avoid
becoming top down or mismatched (Butt et al., 2014).
One cannabis screening and brief intervention program has been trialled in Aboriginal
Community Controlled Health (ACCHO) primary health settings. The Could it be the Gunja?
Project funded by NCPIC and undertaken by a partnership between researchers and six
ACCHOs implemented cannabis screening and brief intervention across six sites (urban,
regional and remote) (Butt et al., 2009; Butt et al., 2014; Howard et al., 2012). During
consultation the project identified that few staff regularly talked to clients about cannabis,
further many reported not feeling comfortable talking about cannabis, yet most reported that
they felt cannabis use was having a significant effect on the local community.
Consequently, the goal of the project was to introduce screening and brief intervention for
cannabis use and cannabis information resources to primary health care clients (resources
are described above). Most importantly, the project developed a comprehensive
implementation plan to ensure that the introduction of screening and brief intervention
included consultation, training and support to staff. As an example of outcomes before the
project started only 20% of clinic staff (including nurses, GPs and health workers) regularly
talked to clients about cannabis. At the end of the project 60% of participants were talking
to their clients about cannabis use (Howard et al., 2012). In addition, at the end of the
project participants felt more comfortable asking about cannabis and felt that they knew
more about cannabis and had the skills to help people who use cannabis (Butt et al., 2014).
The project also highlighted the need to separate screening for cannabis use from other
illicit drugs such as methamphetamines. As other research as shown, when people receive
screening for illicit drugs they may not identify cannabis as an ‘illicit drug’ due to its more
normalised status (Wilson & Butt, 2019).
Given the high rates of cannabis and tobacco co-use, tobacco intervention and quit
smoking programs may also provide an avenue for effective cannabis interventions,
including health promotion and brief intervention (Butt, 2020).
National research has identified that medical practitioners are less likely to ask
pregnant women about cannabis use than tobacco (Gould et al., 2017) and emphasised
the role of practitioners in screening pregnant women for cannabis use. A similar
recommendation has been identified in research focused on Aboriginal women (Brown et
al., 2016; Passey et al., 2014). Given the emerging success of a number of programs
targeting tobacco use among Aboriginal mothers and identification of factors which
promote success (Bovill et al., 2019; Harris et al., 2019), it is possible that similar
screening and brief intervention approaches that can target cannabis in addition to
tobacco are suited to antenatal settings.
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Improving the social determinants
It is widely acknowledged the interventions that target the social determinants of health
will result in reductions in drug use, including cannabis, improve quality of life and reduce
the life expectancy gap between Aboriginal and non-Indigenous Australians (Brown et al.,
2019; Gray & Wilkes, 2010b). Considerable effort is required to target the social
determinants of health if any approach to reducing symptoms of inequality - such as
harmful drug use – are to be successful. Of particular relevance to cannabis use are
interventions which are also linked to mental health and justice involved populations and
therefore include programs which address housing, family and domestic violence,
education for Aboriginal people (Gray & Wilkes, 2010b) and racism within the broader
Australian community.
Youth wellbeing and diversion approaches
Prevention of the uptake of cannabis use among young people is an important
component of reducing cannabis related harm. Considering cannabis use is one
component of at-risk behaviour among young people, holistic approaches which focus on
wellbeing as well as systemic factors across multiple domains are likely the most suitable
interventions. An example of comprehensive approach for at risk young people are those
which promote school retention and target multiple risk factors. The Clontarf Academy is
one such successful approach which uses Australian Rules football as a mechanism of
engaging boys in school, improving self-esteem, developing skills, developing prosocial
behaviour and providing opportunities to experience rewards and achievement. Eighty
per cent (80%) of the young males in the program finish Year 12, compared to a 45%
retention rate for Aboriginal students nationally (Clontarf Foundation, 2018).

Treatment for harmful cannabis use
Treatment approaches for harmful cannabis use and Cannabis Use Disorder include
various counselling approaches, self-help and peer support programs, the provision of
social and vocational skills, residential rehabilitation and, additionally, there is potential for
pharmacotherapy. The international literature shows that treatment for cannabis problems
can be effective (Copeland & Pokorski, 2016) which can inform discussion of best practice.
A complication in the treatment of harmful cannabis use internationally is the observation
that most treatment seekers do not seek treatment until they are experiencing significant
harm and that treatment access is a significant barrier (McGough et al., 2018). Further the
results presented in the preceding sections demonstrate that treatment seeking for
cannabis use among Aboriginal people is low in consideration of the high rates of
prevalence. Thus, it is important to recognise that not only are evidence based treatments
needed, but they need to be easily accessible (Haber & Riordan, 2021).
Counselling based treatment approaches
There are a number of counselling based clinical approaches which have demonstrated
efficacy in treating cannabis and other drug use in non-Aboriginal populations, which
have an evidence base for Aboriginal people. Evidence based approaches to the
treatment of cannabis use include cognitive behaviour therapy (CBT), motivational
enhancement therapy (MET), combination CBT and MET, contingency management
(CM), and family therapy (Copeland et al., 2017; Nordstrom & Levin, 2007) with evidence
emerging for the validity of third wave CBT approaches, such as Acceptance and
Commitment Therapy (ACT) and Mindfulness Based Relapse Prevention (Copeland et
al., 2017), with many of these approaches having been used with Aboriginal people
(Haber & Riordan, 2021).
The strongest evidence for the treatment of harmful cannabis use is for CBT, MET
and combined CBT-MET (Copeland et al., 2017), and CBT-MET with reward for
abstinence (CM) (Gates et al., 2016), however a recent systematic review suggested that
MET did not reduce cannabis use among adolescents (Steele et al., 2020). Both CBT
and MET have been successfully adapted for use among Aboriginal people for a range of
other mental health and AOD presentations (Bennett‐levy et al., 2014; Nagel et al., 2009).
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As such CBT and MET approaches are recommended as therapeutic approaches for
Aboriginal people presenting for treatment with harmful cannabis use.
A specific CBT based approach which has demonstrated acceptability for Aboriginal
people is the Community Reinforcement Approach (CRA) (Calabria et al., 2013), which
uses CBT and MET principles to identify alternatives to drug and alcohol use and to
develop strategies to reward non-use. CRA Family Training (CRAFT) works with the
family as well as the client by supporting the family to remove factors that reinforce
substance use and promote factors that reinforce not using. The involvement of family in
the treatment of drug use has been identified as an important factor in treatment. Calabria
and colleagues worked with Aboriginal clients of an Aboriginal Community Controlled
Organisation using the CRA/CRAFT approach, with reports it was found to be acceptable
and feasible. Similarly CRAFT was highly acceptable with family members or friends who
wanted to support their loved one to start alcohol treatment (Calabria et al., 2013).
Importantly, any discussion of counselling approaches to drug use needs to consider
the common factors of therapy (Wampold, 2015). The common factors include the
relationship between the client and the practitioner, the explanation of the concern, and
the specifics of treatment itself. Studies regarding common factors emphasise that
treatment outcomes are not simply linked to the approach of a practitioner but also to the
relationship between the client and practitioner. In the alcohol and drug context Project
Match, the largest alcohol treatment study conducted to date in the USA, found that
therapy type did not predict outcome, the authors concluded that therapeutic relationship
was critical in outcome (Project MATCH Group, 1997). While much research focuses on
the efficacy of a certain therapy type, often it is the relationship between the client and the
service provider, or indeed factors external to therapy which facilitate change (Wampold,
2015). Thus, a focus on engagement and relationship building with Aboriginal clients
should be regarded with as much significance as the therapeutic approach. Factors which
negatively influence engagement include a lack of cultural appropriateness of service
delivery, language barriers, concerns about confidentiality, shame, fear of being judged,
or discrimination, fear of child removal, and difficulties with accessibility (Haber &
Riordan, 2021). Among at risk young women, treatment and counselling approaches
which are based on yarning, opportunistic, and available on demand (not long waitlists),
have been identified by young women as factors which facilitate engagement and help
seeking (Wilson & Butt, 2019).
Peer support approaches
Peer support approaches such as 12-step programs and SMART Recovery are an
important component of the treatment mix for substance use. Twelve step programs
(Alcoholics Anonymous) have had mixed feedback in regards to cultural appropriateness of
the approach (Taylor et al., 2010); aspects of 12 step approaches, such as gender mixing
and confrontational therapy are not considered culturally safe by some commentators.
Further, the disease model has also been criticised as disempowering (Miller & Rowse,
1995). That said, workers with lived experience make peer lead programs appealing.
SMART Recovery is an alternative secular peer support program using a CBT framework.
A recent study using a Delphi approach investigated the cultural utility of SMART Recovery
for Aboriginal people (Dale et al., 2021). Results highlighted the importance of Aboriginal
consultation and highlighted the need for the implementation of a culturally adapted
facilitation handbook for SMART Recovery that included cultural and contextual information
and was informed by the lived experience of Aboriginal drug users.
Residential rehabilitation
Generally, residential treatment has not been found to be more effective than nonresidential treatment (Babor et al., 2008), however it is a popular treatment option for
those with severe drug use problems. There is some evidence that rehabilitation may be
more effective for particular groups of clients with more complex psychosocial
circumstances and more significant deterioration in functioning (Gray & Wilkes, 2010b).
Taylor and colleagues surmised that mainstream residential rehabilitation was
problematic due to cultural incongruence (different conceptions of illness, power

Published by Edith Cowan University, 2022

23

Journal of the Australian Indigenous HealthInfoNet, Vol. 3 [2022], Iss. 3, Art. 1

imbalances, regimented time-tabling) and lack of Aboriginal staff (Taylor et al., 2010).
Nathan and colleagues (Nathan et al., 2020) highlighted the need for holistic residential
rehabilitation for young Aboriginal people who are experiencing drug related harm and
reported on the outcomes of an Aboriginal program which included a residential program.
The program duration was between 30 days and three months and included holistic
treatment incorporating life skills, case management and therapy within a drug free
environment (Nathan et al., 2020). The authors noted high levels of case complexity
among the client group including high levels of suicidal ideation, self-harm, justice
involvement and unstable accommodation among participants at commencement of
treatment (Nathan et al., 2020). With respect to cannabis use the results identified that
the majority of those using cannabis at intake were still using cannabis at three months
post treatment (64%), however there was a significant reduction in frequency of cannabis
use. Looking beyond the metrics of drug use, the authors found that self-harm and justice
involvement had significantly decreased (Nathan et al., 2020). The results demonstrate
the importance of treatment approaches which target a range of determinants of health
and are culturally appropriate. A final note on the use of residential rehabilitation is the
lack of funding for through care, or follow up (Gray et al., 2014) to support those leaving
rehabilitation to maintain treatment gains when returning home. Without adequate
through care support the investment in rehabilitation can be short lived.
Pharmacological approaches
There are no current evidence based pharmacological approaches to the treatment of
cannabis use approved in Australia, although a number of recent trials have shown
promise (Vandrey & Haney, 2009) (Copeland & Pokorski, 2016) (Freeman et al., 2020;
Kondo et al., 2020). Potential pharmacological approaches include agonists, medications
to reduce craving and medications to address the symptoms of withdrawal. A number of
studies are examining the effectiveness of medications to address symptoms of
withdrawal such as sleep (zolpidem) and reduce anxiety (buspirone) (National Institute on
Drug Abuse, 2021). Other agents being studied include those which may reduce
withdrawal by inhibiting the breakdown of the body’s own cannabinoids. For those who
use tobacco with cannabis, following assessment of nicotine addiction and withdrawal,
nicotine replacement therapy may be indicated to manage co-occurring symptoms of
nicotine withdrawal (Bittoun, 2016).
Agonist therapies are the most promising, such as nabiximols and nabilone, which
have been found to reduce measures of withdrawal and relapse in initial trials and
warrant further exploration in the management of aspects of cannabis-use disorder
(Copeland & Pokorski, 2016). Similarly CBD has also shown promise, a recent
preliminary study suggested that CBD was marginally more effective than placebo in
reducing cannabis risk and had a low risk safety profile (Freeman et al., 2020).
Co-morbidity and mental health services
Considering the relationship between cannabis use and mental ill-health and high rates of
comorbidity, there is need for mental health services to have capacity to address
cannabis use, for drug treatment services to have capacity to address mental health
presentations, and for services which address comorbidity. Implied in this is the need for
workplace capacity building within both the substance-use treatment sector and the
mental health sector.
In terms of interventions to address comorbidity, best practice guidelines suggest
that comorbid substance-use and mental health disorders should be assessed and
treated concurrently (Marel et al., 2016) (Copeland & Pokorski, 2016), or, in line with
patient centre care in the order identified by the client (Marel et al., 2016). Research has
provided some preliminary support for brief MET interventions; in a small sample of
Aboriginal people in remote communities with AOD and mental health comorbidity, brief
MET was found to reduce symptoms of mental health and AOD use disorders (Nagel et
al., 2009). In summary, despite the lack of research evidence there are a range of
treatment and prevention approaches that can address cannabis related harms.
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Policy approaches to cannabis use
Cannabis and health policy
There are no national policies relating specifically to cannabis use among Aboriginal
people. The health policy frameworks relevant to cannabis use and cannabis related
harms include the National Drug Strategy 2017-2026 (NDS) (Commonwealth of Australia,
Department of Health., 2017) which highlights a harm mitigation approach whereby policy
focuses on the three pillars of demand reduction, supply reduction and harm reduction,
and the now expired National Aboriginal and Torres Strait Islander Peoples’ Drug
Strategy 2014-2019 (Intergovernmental Committee on Drugs., 2015) which was a sub
strategy of the NDS. The NATSIPDS aimed to improve the health and wellbeing of
Aboriginal and Torres Strait Islander people by preventing and reducing the harmful
effects of AOD on individuals, families, and their communities. The strategy identified four
priority areas: (1) build capacity of AOD workforce (2) increase access to culturally
appropriate programs (3) strengthen partnerships (4) establish meaningful performance
measures (Intergovernmental Committee on Drugs 2015; Gray et al., 2014). Critics of the
strategy suggest that it lacked a framework from which to achieve the priority areas and
that fragmented policy and service delivery would likely continue (Gray et al., 2014).
Although cannabis is mentioned in the NATSIPDS it does not have any associated
policies or priorities. In addition, reduction in substance use is embedded within the
national Closing the Gap targets and outcomes (Australian Government, 2020). It is also
relevant to note that community organisations have emphasised the need for a health
policy and health response to cannabis use as holding better potential than current
policies which focus on the legal status of cannabis use as a deterrent (Victorian
Aboriginal Legal Service, 2020).
Changes in policy that are emerging at a national level relate to the medicinal use of
cannabis and as such are not reviewed. The summary below examines policy
surrounding the legality and criminalisation of cannabis and cannabis use.

Approaches to cannabis regulation
There are many different legal frameworks governing the use and supply of drugs such
as cannabis - the primary approaches are: full prohibition (use, possession and supply
are criminal offences), depenalisation (use and possession are still criminal offences but
with lighter penalties e.g. education and/or treatment), decriminalisation (use and
possession are not criminal, criminal penalties are replaced with civil penalties, and drug
supply remains a criminal offence) and legalisation (use of a drug is legal as is drug
supply) (Lee & Ritter, 2016).
In Australia, as in much of the world, the primary policy response to cannabis use
has included prohibition, depenalisation and decriminalisation. These approaches focus
on reducing drug related harm via the legal framework. As described in the preceding
sections the criminalisation of recreational cannabis use can result in significant negative
consequences (including incarceration and fines), further it is resource intensive and can
limit people’s willingness to engage in treatment, prevention and in research participation
(Butt et al., 2014; Hall et al., 2019). In addition, cannabis harms are considered moderate
in comparison to other illicit drugs such as opioids and alcohol (Degenhardt et al., 2013;
Hall et al., 2019). This has prompted governments around the world to reconsider
cannabis. Recently the cannabis policy landscape has fundamentally changed with the
legalisation of cannabis use and supply for recreational purposes, particularly in the
Americas (Decorte et al., 2020). In 2013, Uruguay was the first country to legalise and
regulate cannabis use for recreational purposes. Recreational cannabis is now legal in 18
US states (Wikipedia, 2021), and across Canada (Decorte et al., 2020). The legalisation
of cannabis in the Americas has stimulated consideration of cannabis legalisation in
many countries (Decorte et al., 2020). In 2020, a proposal to legalise recreational
cannabis in New Zealand was narrowly defeated in a referendum (50.7% against)
(Fischer & Hall, 2021). In Australia, the ACT legalised the possession and cultivation of
cannabis as of 31 January 2021 (Mannheim & Lowrey, 2020) and the legislation of
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cannabis for recreational use is also being considered in Victoria (Parliament of Victoria
Legislative Council Legal and Social Issues Committee, 2021). There are no other
Australian jurisdictions which at the time of writing have cannabis legalisation proposals
under active consideration. However, given the momentum internationally, it is timely to
consider the international evidence on the impact of cannabis legalisation, and to
consider its potential implications for Aboriginal people and Australia more broadly. This
and future reviews of international regulations will inform the cannabis legalisation debate
which is likely to increase in this country in coming years.
Australia has a long history of cannabis reforms beginning in South Australia in 1987,
with the implementation of Australia’s first Prohibition with Civil Penalties Scheme,
followed by similar schemes in the ACT (1992), the NT (1996) and briefly in WA (200408) (Hughes, 2020). Under these schemes cannabis possession and use remains illegal
but, much like speeding in a motor vehicle, is subject to civil (fines) rather than criminal
(record and potential jail) penalties if the fine is paid by the due date. Prohibition with
Cautioning and Diversion (to treatment or education) for first, second or third offenders
depending on jurisdiction, operates for cannabis in Qld, NSW, Vic, and Tas. The efficacy
and impact of these approaches for Aboriginal people has not been adequately
described, and concern remains regarding the heightened unintended impact of nonpayment of fines for Aboriginal people (Spiers & Gilbert, 2011).
In contrast, in the US and Canada, the legalisation models of cannabis policy applied
can be described as profit-driven commercialisation, similar to the legal tobacco and
alcohol space. While it is too early to say what the definitive impacts of fully
commercialised legal cannabis markets are, the salient findings which have relevance for
Australia, and in particular Aboriginal people are summarised below.
Selected evidence on fully commercial legal cannabis markets
Research on the US and Canadian cannabis market is being published at a rapid rate
and there is not the space here to cover it all. Rather the most salient findings to date with
potential relevance to Aboriginal people are summarised.
Firstly, unsurprisingly there have been large (>80%) and rapid reductions in cannabis
related convictions as a result of cannabis legalisation (e.g. Mosher & Atkins, 2020) but
youth are often excluded from the legalisation provisions and there appears to have been
some refocusing of police resources towards young cannabis users (Fischer et al., 2021).
Furthermore, there is evidence emerging that in Alaska, for example, while there were
declines in the proportion of black youth apprehended after legalisation, there were no
changes for Indigenous youth, which remained at over twice the rate of white youth after
legalisation (Firth et al., 2020).
Overall impacts of legalisation on rates of cannabis use seem mixed. While there is
no substantial evidence on increases in rates of regular use by young people
(Zuckermann et al., 2021) and pregnant women (Skelton et al., 2021), use by adult
regular users (Smart & Pacula, 2019), and in particular ‘daily or almost daily’ use
(Rotermann, 2021), has increased. Furthermore, given the strong relationship between
drug price, use and harm, it is also of concern that cannabis prices have fallen rapidly in
legalisation states in the US. For example in Colorado the price of cannabis flower
(heads) dropped by about half in the first four years and the proportion of total market
share held by high potency cannabis products (e.g. hash, waxes, shatter and vape
cartridges) doubled in the same period (Orens et al., 2018). Thus, there is concern that
legalisation may increase rates of use and the accessibility of higher potency products.
Similar to the alcohol and tobacco industries, the impact of cannabis industry activity
is important to acknowledge. Early on there was evidence of industry lobbying against
public health regulations (Subritzky et al., 2016). Furthermore, industry documents
showed that, like the tobacco industry before them, the cannabis industry have targeted
heavy users (Subritzky et al., 2016). This strategy is consistent with subsequent Colorado
market data which showed that ‘daily or near-daily’ users comprised 22% of cannabis
users but were responsible for 71% of the cannabis consumed in the legal market (Orens
et al., 2018). Despite attempts to keep them at bay and have a more public-healthfocused system, multinational alcohol, tobacco and soft drink companies have taken big
shares in the Canadian cannabis market (Hall et al., 2019). While many of the laws aim to
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limit advertising of cannabis products, especially to youth, there is evidence that
companies are getting around restrictions on advertising by going to social media and
YouTube (Subritzky et al., 2020) and there is evidence emerging that adolescents are
seeing this alternative media content and their cannabis use is related to this media
exposure (Whitehill et al. 2020). Particularly relevant in this context, just like with alcohol,
several US states have found that cannabis retailers tend to locate in areas with more
racial and ethnic minority residents, more poverty, and more alcohol outlets (Unger et al.,
2020) and the greater the density of cannabis outlets, the greater the cannabis use,
frequency of use and future intention to use (Pedersen et al., 2021). In considering future
options for Australian cannabis policy the impacts of industry, and their potential impact
on Aboriginal communities, need to be understood.
Thus, evidence that has accrued to date from the fully commercialised cannabis
legalisation models in North America suggests Australia should be wary about taking a
similar approach. Many of the observed problems of commercial cannabis markets have
parallels with the tobacco and alcohol markets that have caused considerable harm to
Australians in general, and Aboriginal people in particular. Furthermore, already we are
seeing in the US and Canada that, while legalisation has resulted in a rapid reduction in
the significant social costs of criminalisation, which has disproportionately impacted
people of colour, the public health burden of commercialisation of cannabis does seem
substantial and disproportionately felt by Indigenous people and communities
characterised by social and economic disadvantage.
Middle ground options
Considering the above, a number of scholars (e.g. Kilmer, 2017) have pointed out that there
are a range of ‘middle ground’ policy options for cannabis between strict prohibition with
severe penalties at one end to full profit-driven commercialism. These include: home
cannabis cultivation, cannabis social clubs, non-profit cannabis companies, and cannabis
community trusts (Caulkins & Kilmer, 2016). These middle ground options have received
little media or research attention and are thus not considered by policy makers and the
public when considering the way forward for cannabis policy (Decorte & Pardal, 2017), but
there are a number which have real promise as ways of legalising cannabis without
repeating the public health disasters of decades of profit driven tobacco and alcohol
markets (Decorte et al., 2020). In the current context there are three of particular note:
Cannabis Social Clubs, Cannabis Community Trusts and Mixed Models. These three
models aim respectively to: target public health goals by meeting supply needs but
regulating a consumer’s use and integrating health warnings; prevent and reduce cannabisrelated health and social harms at a local level by involving communities in decisions about
cannabis sales and directing profit back into positive community initiatives such as drug
treatment and prevention activities; or, provide a mixture of approaches which can provide
legal access to cannabis in a way that reduces the adverse impacts of criminalisation on
users, families and communities, and avoids or minimises many of the adverse public
health effects of profit-driven commercialisation (Decorte, 2018) (Wilkins, 2018; Wilkins &
Rychert, 2020). It is unlikely that any single middle ground model will meet the needs of all
cannabis users and affected communities. Rather, should governments wish to legalise
cannabis, approaches comprising a number of elements of the ‘middle ground’ options
tailored to meet the local needs and issues regarding cannabis, are possible. Embedded in
these approaches are the need for self-determination and genuine community consultation
around policy development and implementation.

Future directions
High prevalence of cannabis use coupled with a lack of available resources to address
cannabis related harms warrants attention from researchers, health practitioners and
policy makers. The current review has drawn from a wide variety of sources, and it is
clear there is a need for more detailed research into cannabis use, its social context of
use and related harms among Aboriginal people. Thus, future research needs to include
high quality epidemiological research, longitudinal research, and qualitative research. The
use of cannabis by young people, cannabis and mental health comorbidity, and
community understanding of cannabis use are three areas of need.
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There is a need for increased investment in existing structures and services to better
address cannabis related harms. Cannabis specific resources for health promotion and
prevention that are appropriately resourced, designed and evaluated are clearly
indicated. Increasing the capacity of existing drug treatment, tobacco cessation, and
social and emotional wellbeing (including mental health) services to responding to
cannabis use is also needed. Whole of community approaches are also indicated and
warrant further attention. The development of community approaches requires sufficient
time frames from which to engage communities in the topic of cannabis, develop
appropriate responses and to evaluate them. All approaches to cannabis related harms
need to be guided by best practice principles in the development and evaluation of
culturally safe services and requires community ownership, oversight and sustained
funding.
Finally, as the international discourse around cannabis moves away from prohibition
and towards legalisation, considerable community consultation is required to identify
suitable approaches to regulation that minimises the risks of legislation which criminalises
those who use cannabis and legislation which is based on profit-driven commercialisation
of use.

Concluding comments
As highlighted by the UNODC there has been a global increase in the potency of
cannabis, this increase has been matched by a reduction in the perception that cannabis
use is harmful. These developments highlight the need for ongoing research and further
investment in health-based approaches to minimise cannabis related harm more broadly.
International research shows that cannabis use, particularly when commencing in
adolescence, has individual and community, health, mental health and wellbeing harms.
Although detailed epidemiological data is lacking, the research available
demonstrates that among Aboriginal people cannabis use prevalence is high, and among
some communities cannabis use is normalised; prevalence among young people is high;
and there are significant rates of cannabis use dependence. Furthermore, the use of
cannabis with alcohol, tobacco and other drugs is concerning and warrants investigation.
The co-use of cannabis and tobacco is particularly noteworthy. The comorbidity of
cannabis use and mental health disorders was clearly noted in the review, and has
implications for the prevention and treatment of cannabis related harms. Harmful
cannabis use is likely to arise from social disadvantage and perpetuates it. Cannabis is
related to a range of psychosocial harms including engagement in the criminal justice
system, violence, early withdrawal from education, and lack of employment, as well as
the impacts on mental health.
There is a lack of evidence base to identify or review best practice approaches in
cannabis prevention and treatment at the individual, family and community level. Of
particular concern is the lack of programs and resources with community ownership or
co-design. There is a clear need for the development of culturally safe prevention and
treatment resources that can address cannabis related harms. That said, a range of
promising opportunities exist; including school-based prevention, health promotion
resources, and increasing capacity in mental health and AOD services to better meet the
needs of cannabis related presentations. These opportunities can be maximised if the
best practice principles of focusing on social and emotional wellbeing, cultural safety,
self-determination and adequate resourcing are adhered to, alongside broader
approaches to improving the social determinants of health. Finally, the review considered
the legal status of cannabis and identified the range of policy options that exist as an
alternative to prohibition of cannabis.
Cannabis related harms and the prevalence of cannabis use receive scant attention,
yet they are concerning and are an important item on the Aboriginal health agenda.
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